Last modified: 2014-04-03
Abstract
Introduction: Mucopolysaccharidosis type IVA is a rare lysosomal storage disease caused by a deficiency of N-acetylgalactosamine-6-sulfatase. Studies usually focus on skeletal abnormalities and their consequences. This study explores the neurological manifestations in a cohort of mucopolysaccharidosis type IVA patients, with a detailed focus on brain and spinal MRI findings.
Methods: We performed a cross-sectional study involving nine patients with a biochemical confirmation of mucopolysaccharidosis type IVA. The protocol consists of a comprehensive clinical examination and brain/spinal cord MRI analysis for all subjects.
Results: The mean age was 16.4 years (± 5.7) and the mean onset of symptoms was 11.5 months (± 6.3). Overall, cognition was spared in all but one patient and motor weakness was a constant finding in all patients. Deep sensation impairment was found in six patients (table 1). The brain MRIs showed non-specific white matter changes in two patients. Other abnormalities such as clival hypoplasia, basilar invagination, and arachnoid cists appeared in seven of the nine patients. Eight patients presented spinal cord compression, and in three of them, two spinal levels were compromised. Odontoid hypoplasia and degenerative features in the neuroaxis were present in all patients (table 2).
Conclusion: Our experience with mucopolysaccharidosis type IVA patients supports the evidence of CNS involvement. We emphasize the importance of regular clinical assessments with complete MRI studies, as an attempt to detect the early signs of spinal cord compression. This evaluation may be especially important before surgical interventions, as occult lesions may become symptomatic and promote postoperative unfavorable outcomes.
Keywords
References
1. Baker E, Guo XH, Orsborn AM, Sutherland GR, Callen DF, Hopwood JJ, Morris CP: The morquio A syndrome (mucopolysaccharidosis IVA) gene maps to 16q24.3. Am J Hum Genet 1993, 52(1):96-98.
2. Davison JE, Kearney S, Horton J, Foster K, Peet AC, Hendriksz CJ: Intellectual and neurological functioning in Morquio syndrome (MPS IVa). J Inherit Metab Dis 2013, 36(2):323-328.
3. Nelson J, Thomas PS: Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part III: Odontoid dysplasia. Clin Genet 1988, 33(2):126-130.
4. Solanki GA, Martin KW, Theroux MC, Lampe C, White KK, Shediac R, Lampe CG, Beck M, Mackenzie WG, Hendriksz CJ et al: Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J Inherit Metab Dis 2013, 36(2):339-355.
5. Giugliani R, Harmatz P, Wraith JE: Management guidelines for mucopolysaccharidosis VI. Pediatrics 2007, 120(2):405-418.
6. Hughes DG, Chadderton RD, Cowie RA, Wraith JE, Jenkins JP: MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology 1997, 39(5):381-385.
7. Stevens JM, Kendall BE, Crockard HA, Ransford A: The odontoid process in Morquio-Brailsford's disease. The effects of occipitocervical fusion. J Bone Joint Surg Br 1991, 73(5):851-858.
8. Ashraf J, Crockard HA, Ransford AO, Stevens JM: Transoral decompression and posterior stabilisation in Morquio's disease. Arch Dis Child 1991, 66(11):1318-1321.
9. Möllmann C, Lampe CG, Müller-Forell W, Scarpa M, Harmatz P, Schwarz M, Beck M, Lampe C: Development of a Scoring System to Evaluate the Severity of Craniocervical Spinal Cord Compression in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome). JIMD Rep 2013.